Canada · Delayed Price · Currency is CAD InnoCan Pharma Company Description
InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally.
The company operates through two segments, Online sales and Other Operations. The company develops a cannabidiol (CBD)-loaded liposome drug delivery platform (CBD-LPT), which is in the preclinical trial phase to treat chronic pain management for human and veterinary health sectors.
It also offers a pain-relieving topical composition, as well as compositions for the treatment of hemorrhoid, psoriasis of the scalp, vaginal atrophy, and diabetic symptoms.
The company is also involved in development, manufacture, and marketing of cosmetic products. InnoCan Pharma Corporation was founded in 2017 and is headquartered in Calgary, Canada.
| Country | Canada |
| Founded | 2017 |
| Industry | Household & Personal Products |
| Sector | Consumer Staples |
| Employees | 5 |
| CEO | Iris Bincovich |
Contact Details
Address: 1015, 926 – 5 Avenue SW Calgary, AB T2P 0N7 Canada | |
| Phone | 403-777-1519 |
| Website | innocanpharma.com |
Stock Details
| Ticker Symbol | INNO |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | CA45783P1027 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Roni Kamhi | Chief Operating Officer, Chief Executive Officer of B.I. Sky Global LTD and Director |
| Iris Bincovich | Chief Executive Officer and Interim Chairwoman |
| Nelson Harvey Halpern F.C.A., FCPA | Chief Financial Officer |
| Eyal Flom L.L.M., M.B.A. | Company Secretary, General Counsel and Director |
| Dr. Eyal Kalo | Vice President of Research and Development |